Bonnette W

References (1)

Title : Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor - Wyatt_2020_J.Pharmacol.Exp.Ther_372_339

Author(s) : Wyatt RM , Fraser I , Welty N , Lord B , Wennerholm M , Sutton S , Ameriks MK , Dugovic C , Yun S , White A , Nguyen L , Koudriakova T , Tian G , Suarez J , Szewczuk L , Bonnette W , Ahn K , Ghosh B , Flores CM , Connolly PJ , Zhu B , Macielag MJ , Brandt MR , Chevalier K , Zhang SP , Lovenberg T , Bonaventure P

Ref : Journal of Pharmacology & Experimental Therapeutics , 372 :339 , 2020

Abstract :

PubMedSearch : Wyatt_2020_J.Pharmacol.Exp.Ther_372_339

PubMedID: 31818916

Bonnette W

References (1)

1. Pharmacologic Characterization of JNJ-42226314, [1-(4-Fluorophenyl)indol-5-yl]-[3-[4-(thiazole-2-carbonyl)piperazin-1-yl]azetidin-1-yl]methanone, a Reversible, Selective, and Potent Monoacylglycerol Lipase Inhibitor - Wyatt_2020_J.Pharmacol.Exp.Ther_372_339